These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 21813829

  • 1. Three kidneys, two diseases, one antibody?
    Lorcy N, Rioux-Leclercq N, Lombard ML, Le Pogamp P, Vigneau C.
    Nephrol Dial Transplant; 2011 Nov; 26(11):3811-3. PubMed ID: 21813829
    [Abstract] [Full Text] [Related]

  • 2. Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles.
    Skerka C, Licht C, Mengel M, Uzonyi B, Strobel S, Zipfel PF, Józsi M.
    Mol Immunol; 2009 Sep; 46(14):2801-7. PubMed ID: 19640589
    [Abstract] [Full Text] [Related]

  • 3. Thrombotic microangiopathy in an allograft kidney: a diagnostic challenge.
    Chan GS, Tse KC, Lam MF, Chan KW.
    Histopathology; 2006 May; 48(6):775-6. PubMed ID: 16681703
    [No Abstract] [Full Text] [Related]

  • 4. Pathological aspects of membranoproliferative glomerulonephritis (MPGN) and haemolytic uraemic syndrome (HUS) / thrombocytic thrombopenic purpura (TTP).
    Benz K, Amann K.
    Thromb Haemost; 2009 Feb; 101(2):265-70. PubMed ID: 19190808
    [Abstract] [Full Text] [Related]

  • 5. Selective disappearance of C3NeF IgG autoantibody in the plasma of a patient with membranoproliferative glomerulonephritis following renal transplantation.
    Frémeaux-Bacchi V, Weiss L, Brun P, Kazatchkine MD.
    Nephrol Dial Transplant; 1994 Feb; 9(7):811-4. PubMed ID: 7970124
    [Abstract] [Full Text] [Related]

  • 6. Anti-factor H autoantibody-associated hemolytic uremic syndrome: review of literature of the autoimmune form of HUS.
    Dragon-Durey MA, Blanc C, Garnier A, Hofer J, Sethi SK, Zimmerhackl LB.
    Semin Thromb Hemost; 2010 Sep; 36(6):633-40. PubMed ID: 20865640
    [Abstract] [Full Text] [Related]

  • 7. Successful pre-transplant management of a patient with anti-factor H autoantibodies-associated haemolytic uraemic syndrome.
    Kwon T, Dragon-Durey MA, Macher MA, Baudouin V, Maisin A, Peuchmaur M, Fremeaux-Bacchi V, Loirat C.
    Nephrol Dial Transplant; 2008 Jun; 23(6):2088-90. PubMed ID: 18326881
    [No Abstract] [Full Text] [Related]

  • 8. C3 Glomerulopathy and Related Disorders in Children: Etiology-Phenotype Correlation and Outcomes.
    Wong EKS, Marchbank KJ, Lomax-Browne H, Pappworth IY, Denton H, Cooke K, Ward S, McLoughlin AC, Richardson G, Wilson V, Harris CL, Morgan BP, Hakobyan S, McAlinden P, Gale DP, Maxwell H, Christian M, Malcomson R, Goodship THJ, Marks SD, Pickering MC, Kavanagh D, Cook HT, Johnson SA, MPGN/DDD/C3 Glomerulopathy Rare Disease Group and National Study of MPGN/DDD/C3 Glomerulopathy Investigators.
    Clin J Am Soc Nephrol; 2021 Nov; 16(11):1639-1651. PubMed ID: 34551983
    [Abstract] [Full Text] [Related]

  • 9. Factor H autoantibodies in membranoproliferative glomerulonephritis.
    Goodship TH, Pappworth IY, Toth T, Denton M, Houlberg K, McCormick F, Warland D, Moore I, Hunze EM, Staniforth SJ, Hayes C, Cavalcante DP, Kavanagh D, Strain L, Herbert AP, Schmidt CQ, Barlow PN, Harris CL, Marchbank KJ.
    Mol Immunol; 2012 Oct; 52(3-4):200-6. PubMed ID: 22721707
    [Abstract] [Full Text] [Related]

  • 10. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
    Polito MG, Kirsztajn GM.
    J Bras Nefrol; 2010 Oct; 32(3):303-15. PubMed ID: 21103695
    [Abstract] [Full Text] [Related]

  • 11. Complement factor H deficiency and posttransplantation glomerulonephritis with isolated C3 deposits.
    Boyer O, Noël LH, Balzamo E, Guest G, Biebuyck N, Charbit M, Salomon R, Frémeaux-Bacchi V, Niaudet P.
    Am J Kidney Dis; 2008 Apr; 51(4):671-7. PubMed ID: 18371543
    [Abstract] [Full Text] [Related]

  • 12. Thrombotic microangiopathy after kidney transplantation.
    Ponticelli C, Banfi G.
    Transpl Int; 2006 Oct; 19(10):789-94. PubMed ID: 16961769
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Treatment of thrombotic microangiopathies].
    Debourdeau P, Zammit C, Souleau B, Védrine L, Farge-Bancel D.
    Ann Med Interne (Paris); 1999 Sep; 150(5):374-87. PubMed ID: 10544747
    [Abstract] [Full Text] [Related]

  • 16. [Thrombotic microangiopathy after kidney transplantation].
    Basić-Jukić N, Jurić I, Brunetta-Gavranić B, Kes P, Bubić-Filipi L, Glavas-Boras S.
    Acta Med Croatica; 2008 Sep; 62 Suppl 1():93-6. PubMed ID: 18578340
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Plasma exchanges and immunosuppression for anti-complement factor H associated hemolytic uremic syndrome.
    Khandelwal P, Sinha A, Hari P, Bagga A.
    Indian Pediatr; 2014 Oct; 51(10):833-5. PubMed ID: 25362019
    [Abstract] [Full Text] [Related]

  • 20. The autoimmune disease DEAP-hemolytic uremic syndrome.
    Skerka C, Zipfel PF, Müller D, Micklisch S, Riedl M, Zimmerhackl LB, Hofer J.
    Semin Thromb Hemost; 2010 Sep; 36(6):625-32. PubMed ID: 20865639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.